SPOTLIGHT: New CEO to run GSK from London

When Andrew Witty (photo) takes over as CEO in May, he'll be running GlaxoSmithKline from London rather than from the U.S. HQ in Philadelphia as his predecessor Jean-Pierre Garnier did. No significant staff or resources will be relocated, and the company will continue to have a "dual headquarters" in both cities. Witty has been living in the UK as chief of the company's European operations. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.